摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

ethyl (2S,3S)-2-(p-methoxyphenylamino)-3-methyl-4-oxopentanoate

中文名称
——
中文别名
——
英文名称
ethyl (2S,3S)-2-(p-methoxyphenylamino)-3-methyl-4-oxopentanoate
英文别名
ethyl (2S,3S)-2-(4-methoxyanilino)-3-methyl-4-oxopentanoate
ethyl (2S,3S)-2-(p-methoxyphenylamino)-3-methyl-4-oxopentanoate化学式
CAS
——
化学式
C15H21NO4
mdl
——
分子量
279.336
InChiKey
GBGNRFZGTLOKJF-YGRLFVJLSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    20
  • 可旋转键数:
    8
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.47
  • 拓扑面积:
    64.6
  • 氢给体数:
    1
  • 氢受体数:
    5

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Compounds and compositions for use in the prevention and treatment of obesity and related syndromes
    申请人:Chapal Nicolas
    公开号:US20060223884A1
    公开(公告)日:2006-10-05
    The invention relates to 4-hydroxyisoleucine, isomers, analogs, lactones, salts, and prodrugs thereof, to processes for their preparation, and to pharmaceutical compositions comprising the same. More particularly, the invention relates to the use of those compounds in the prevention and treatment of obesity and related syndromes.
    本发明涉及4-羟基异亮氨酸、其同分异构体、类似物、内酯、盐和前药,以及它们的制备过程,以及包含它们的药物组合物。更具体地说,本发明涉及这些化合物在预防和治疗肥胖及相关综合症中的用途。
  • Organocatalysis in Ionic Liquids: Highly Efficient<scp>l</scp>-Proline-Catalyzed Direct Asymmetric Mannich Reactions Involving Ketone and Aldehyde Nucleophiles
    作者:Carlos F. Barbas III、Naidu S. Chowdari、D. B. Ramachary
    DOI:10.1055/s-2003-41483
    日期:——
    asymmetric Mannich reactions of N-PMP protected a-imino ethyl glyoxylate with various alde- hydes and ketones in ionic liquids afforded both a- and b-amino acid derivatives with excellent yields and enantioselectivities, providing facile product isolation, catalyst recycling, and signifi- cantly improved reaction rates, ca 4- to 50-fold. Three component Mannich reactions involving other imines also
    脯氨酸催化的 N-PMP 保护的 α-亚氨基乙醛酸乙酯与各种醛和酮在离子液体中的直接不对称曼尼希反应提供了具有优异产率和对映选择性的 a-和 b-氨基酸衍生物,提供了容易的产物分离和催化剂回收,并且显着提高了反应速率,大约 4 到 50 倍。涉及其他亚胺的三组分曼尼希反应也适用于离子液体。离子液体溶剂在该反应中的显着优点和局限性已被揭示。
  • [EN] ORGANOCATALYSTS AND METHODS OF USE IN CHEMICAL SYNTHESIS<br/>[FR] ORGANOCATALYSEURS ET PROCEDES D'UTILISATION DE CES DERNIERS DANS LA SYNTHESE CHIMIQUE
    申请人:STC UNM
    公开号:WO2006007586A1
    公开(公告)日:2006-01-19
    The present invention pertains generally to compositions comprising organocatalysts that facilitate stereo-selective reactions and the method of their synthesis and use. Particularly, the invention relates to metal-free organocatalysts for facilitation of stereo-­selective reactions, and the method of their synthesis and use. These compounds have the structure of the Formulas (I) and (II). Where X is independently selected from CH2, N-Ra, O, S or C=O; Y is CH2, N-Ra, O, S or C=O, with the proviso that at least one of X or Y is CH2, and preferably both of X and Y are CH2; Ra is H, an optionally substituted C1-C12 alkyl, preferably an optionally substituted C1-C6 alkyl including a C3-C6 cyclic alkyl group, or an optionally substituted aryl group, preferably an optionally substituted phenyl group; Rb is H, an optionally substituted C1-C12 alkyl, preferably an optionally substituted C1-C6 acyclic or a a C3-C6 cyclic alkyl group, CHO, N(Me)O, CO(S)Ra or the group of Formula (III). Where Rc and Rd are each independently H, F, C1, an optionally substituted C1-C20 alkyl, preferably an optionally substituted C1-C12 alkyl, more preferably a C1-C6 alkyl, and an optionally substituted aryl group, or together Rc and Rd form an optionally substituted carbocyclic or optionally substituted heterocyclic ring; R1 is OH, OR, NR'R', NHC(=O)R, NHSO2R; R2 is H, F, C1, an optionally substituted C1-C20 alkyl, preferably an optionally substituted C1­C6 alkyl, an optionally substituted aryl group or a =O group (which establishes a carbonyl group with the carbon to which =O is attached; R3 is H, OH, F, C1, Br, I, Cl, an optionally substituted C1-C20 alkyl, alkenyl or alkynyl ('hydrocarbyl') group, preferably an optionally substituted C1-C6 alkyl, or an optionally substituted aryl, such that the carbon to which R3 is attached has an R or S configuration; R is H, an optionally substituted C1-C20 alkyl, preferably an optionally substituted C1-C6 alkyl, or an optionally substituted aryl group, R' and R' are each independently H, an optionally substituted C1-C20 alkyl group, preferably an optionally substituted C1-C6 alkyl, or an optionally substituted aryl group; or together R' and R' form an optionally substituted heterocyclic, preferably a 4 to 7 membered optionally substituted heterocyclic group or an optionally substituted heteroaryl ring with the nitrogen to which R' and R' are attached; and wherein said compound is free from a metal catalyst.
    本发明涉及一般包括有机催化剂的组合物,该催化剂促进立体选择性反应以及其合成和使用方法。特别地,本发明涉及无金属有机催化剂以促进立体选择性反应,以及其合成和使用方法。这些化合物具有以下结构的式(I)和(II)。其中X独立地选择自CH2、N-Ra、O、S或C=O;Y为CH2、N-Ra、O、S或C=O,但至少X或Y中的一个为CH2,最好是X和Y都为CH2;Ra为H、可选择地取代的C1-C12烷基,最好是可选择地取代的C1-C6烷基,包括C3-C6环烷基,或可选择地取代的芳基,最好是可选择地取代的苯基;Rb为H、可选择地取代的C1-C12烷基,最好是可选择地取代的C1-C6无环或C3-C6环烷基,CHO、N(Me)O、CO(S)Ra或式(III)的基团。其中Rc和Rd各自独立地为H、F、C1、可选择地取代的C1-C20烷基,最好是可选择地取代的C1-C12烷基,更好地是C1-C6烷基,以及可选择地取代的芳基,或者Rc和Rd一起形成可选择地取代的碳环或可选择地取代的杂环;R1为OH、OR、NR'R'、NHC(=O)R、NHSO2R;R2为H、F、C1、可选择地取代的C1-C20烷基,最好是可选择地取代的C1-C6烷基,可选择地取代的芳基或=O基团(与=O连接的碳形成羰基基团);R3为H、OH、F、C1、Br、I、Cl、可选择地取代的C1-C20烷基、烯基或炔基('烃基'),最好是可选择地取代的C1-C6烷基,或可选择地取代的芳基,使得R3连接的碳具有R或S构型;R为H、可选择地取代的C1-C20烷基,最好是可选择地取代的C1-C6烷基,或可选择地取代的芳基,R'和R'各自独立地为H、可选择地取代的C1-C20烷基,最好是可选择地取代的C1-C6烷基,或可选择地取代的芳基;或者R'和R'一起形成可选择地取代的杂环,最好是4到7成员的可选择地取代的杂环基团或与R'和R'连接的氮原子形成可选择地取代的杂芳基环;其中所述化合物不含金属催化剂。
  • A Highly Enantioselective Amino Acid-Catalyzed Route to Functionalized α-Amino Acids
    作者:Armando Córdova、Wolfgang Notz、Guofu Zhong、Juan M. Betancort、Carlos F. Barbas
    DOI:10.1021/ja017270h
    日期:2002.3.1
    enantiomerically pure α-amino acids has intrigued generations of chemists and been the subject of intense research. This report describes a general approach to functionalized α-amino acids based on catalytic asymmetric synthesis. Proline catalyzed Mannich-type reactions of N-PMP-protected α-imino ethyl glyoxylate with a variety of unmodified ketones to provide functionalized α-amino acids in high yields with
    提供对映异构纯 α-氨基酸的合成方法的发展引起了几代化学家的兴趣,并成为深入研究的主题。本报告描述了基于催化不对称合成的功能化 α-氨基酸的一般方法。脯氨酸催化 N-PMP 保护的 α-亚氨基乙醛酸乙酯与各种未修饰的酮的曼尼希型反应,以高产率提供功能化的 α-氨基酸,具有出色的区域选择性、非对映选择性和对映选择性。对七个实例的研究产生了六个,产品 ee 值≥99%。在涉及可以形成非对映异构产物的酮供体的反应中,两个相邻的立体中心在碳-碳键形成时同时产生,具有完全的同步立体控制。显着地,
  • The Scope of the Direct Proline-Catalyzed Asymmetric Addition of Ketones to Imines
    作者:Wolfgang Notz、Shin-ichi Watanabe、Naidu S. Chowdari、Guofu Zhong、Juan M. Betancort、Fujie Tanaka、Carlos F. Barbas
    DOI:10.1002/adsc.200404114
    日期:2004.8
    A full account of catalytic direct asymmetric Mannich-type reactions is presented describing the scope of amino acid-catalyzed additions of unmodified ketones to a large variety of imines. These reactions are performed under very mild, operationally simple, and environmentally friendly and benign conditions employing a one-pot, three-component protocol as well as preformed imines. Typically, products
    提供了催化直接不对称曼尼希型反应的完整说明,描述了氨基酸催化的未修饰酮加到各种亚胺中的范围。这些反应是在非常温和的,操作简单的,环境友好的和良性的条件下进行的,采用一锅,三组分方案以及预先形成的亚胺。通常,获得的产物具有高区域和非对映选择性以及极好的对映选择性。所开发的方法学被用作合成对映体纯的功能化α-氨基酸,γ-内酯,肟功能化氨基酸以及药理学上重要的靶标(如(R)-环己基甘氨酸)的有力方法。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物